Glucobay (Acarbose) fabricated by Bayer has a place with the class of oral antidiabetic drugs (OAD) called alpha-glucosidase inhibitors. With more than one hundred examinations inspecting its part as a treatment for type 2 diabetes and collecting confirmation of its viability in prediabetes, acarbose is a critical intercession alternative all through the hyperglycaemic ailment continuum. What's more, in a few trials acarbose demonstrates cardiovascular advantages at all phases of hyperglycaemia.